News & Events

Stay update
EBMT 43rd annual meeting ▾

EBMT 43rd annual meeting

Location: Marsiglia (Francia)

MolMed at this event: Organising 2 symposia, on Sunday March 26th at 11.00 AM and on Tuesday March 28th at 12.45 AM

Investors

MolMed’s Board of Directors approved the draft financial statements of FY 2016 and convened the shareholders’ meeting
MolMed’s Board of Directors approved the draft financial statements of FY 2016 and convened the shareholders’ meeting ▾

Investors

MolMed and Rocket Pharma establish a collaboration agreement in the field of gene therapy for the treatment of Fanconi Anemia
MolMed and Rocket Pharma establish a collaboration agreement in the field of gene therapy for the treatment of Fanconi Anemia ▾

Investors

MolMed and TTY Biopharm entered into a term sheet to commercialise Zalmoxis® in certain Asian territories
MolMed and TTY Biopharm entered into a term sheet to commercialise Zalmoxis® in certain Asian territories ▾